Tag: society

60 Global Rising Stars from 1,200 Universities will Converge in Singapore for SMU’s 12th Lee Kuan Yew Competition Grand Finals

60 finalists for SG60 milestone edition selected by an international panel of judges and visionary partnersFocus on empowering Urban Solutions and Sustainability to solve...

Finastra and NTT DATA expand Lending Cloud Service to Transform the Banking Experience

A strategic partnership to reshape lending infrastructure, accelerating the global rollout of cutting-edge managed services for the financial services sector SYDNEY, Aug. 11, 2025 /PRNewswire/...

Finastra and NTT DATA expand Lending Cloud Service to Transform the Banking Experience

A strategic partnership to reshape lending infrastructure, accelerating the global rollout of cutting-edge managed services for the financial services sector SYDNEY, Aug. 11, 2025 /PRNewswire/...

Brain Navi Biotechnology’s NaoTrac performs first surgeries in Spain

Brain Navi has officially landed in Spain! TAIPEI, Aug. 11, 2025 /PRNewswire/ -- Such an achievement has been made possible through the first of many...

Savoy Foundation’s 19th Annual Savoy Lecture Series

NEW YORK, Aug. 8, 2025 /PRNewswire/ -- The American Foundation of Savoy Orders, Inc. (Savoy Foundation) will host its 19th annual Lecture Series on...

Questerre reports second quarter 2025 results

THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS

Cielo Announces Extension of Unit Offering

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES
OR FOR DISSEMINATION IN THE UNITED STATES.

Salama Announces Robust H1 2025 Performance Driven by Profitability and Equity Growth

H1 2025 net profit stands at AED 8.25 million driven by profits of AED 7.86 million in the second quarter of 2025Improved equity position...

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

SAN DIEGO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, today reported its second quarter 2025 operating and financial results and reviewed recent business highlights.

Salama Announces Robust H1 2025 Performance Driven by Profitability and Equity Growth

H1 2025 net profit stands at AED 8.25 million driven by profits of AED 7.86 million in the second quarter of 2025Improved equity position...

Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer

– Filing based on pivotal Phase 3 VERITAC-2 clinical trial demonstrating statistically significant and clinically meaningful improvement in median progression-free survival versus fulvestrant –

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsSociety

Marler Clark Urges Parents to Stop Using Nara Organics Whole Milk Organic Powdered Infant Formula Amid Multistate Infant Botulism Outbreak — Product Sold Nationwide...

First-Ever Edie Harper Tile Collection Debuts at Motawi Tileworks

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRAL

Tag: society

60 Global Rising Stars from 1,200 Universities will Converge in Singapore for SMU’s 12th Lee Kuan Yew Competition Grand Finals

Finastra and NTT DATA expand Lending Cloud Service to Transform the Banking Experience

Finastra and NTT DATA expand Lending Cloud Service to Transform the Banking Experience

Brain Navi Biotechnology’s NaoTrac performs first surgeries in Spain

Savoy Foundation’s 19th Annual Savoy Lecture Series

Questerre reports second quarter 2025 results

Cielo Announces Extension of Unit Offering

Salama Announces Robust H1 2025 Performance Driven by Profitability and Equity Growth

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

Salama Announces Robust H1 2025 Performance Driven by Profitability and Equity Growth

Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer

Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates

Cardio Partners Announces the Acquisition of RescueStat

BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us